Background Population-based cancer screening can reduce cancer burden but was
interrupted temporarily due to the COVID-19 pandemic. We estimated the long-term clinical …

Background Many breast, cervical, and colorectal cancer screening programmes were
disrupted due to the COVID-19 pandemic. This study aimed to estimate the effects of five …

It is essential to quantify the impacts of the COVID-19 pandemic on cancer screening,
including for vulnerable sub-populations, to inform the development of evidence-based …

Screening can decrease the burden of breast, cervical, and colorectal cancers. The COVID-
19 pandemic led many countries to suspend cancer screening services as part of their …

Background Cancer‐related deaths over the next decade are expected to increase due to
cancer screening deficits associated with the coronavirus disease 2019 (COVID‐19) …

We evaluated the impact of COVID-19 on cancer screening in Manitoba, Canada using an
interrupted time series (ITS) design and data from Manitoba's population-based, organized …

Importance The COVID-19 pandemic led to sharp declines in cancer screening. However,
the total deficit in screening in the US associated with the pandemic and the differential …

Importance COVID-19 has decreased colorectal cancer screenings. Objective To estimate
the degree to which expanding fecal immunochemical test–based colorectal cancer …

Background Population breast screening services in England were suspended in March
2020 due to the COVID-19 pandemic. Here, we estimate the number of breast cancers …

PURPOSE To examine whether cancer screening prevalence in the United States during
2021 has returned to prepandemic levels using nationally representative data. METHODS …